Phosphorylase ratio and susceptibility to malignant hyperthermia

Area of Science:

• Biochemistry
• Clinical Diagnostics
• Anesthesiology

Background:

• Malignant hyperthermia (MH) is a severe pharmacogenetic disorder of skeletal muscle.
• Screening methods for MH susceptibility are crucial for patient safety during anesthesia.

Purpose of the Study:

• To evaluate the efficacy of the muscle phosphorylase a to total phosphorylase ratio as a screening test for MH susceptibility.
• To compare this biochemical marker with established clinical diagnostic methods for MH.

Main Methods:

• Muscle biopsy samples from 26 patients were analyzed for the phosphorylase ratio.
• Patients underwent standard MH screening tests, including halothane and caffeine contracture responses.
• Data were analyzed to correlate phosphorylase ratios with MH susceptibility determined by standard tests.

Main Results:

• Nine patients were identified as MH susceptible based on established criteria (caffeine threshold ≤2 mM or halothane contracture tension >400 mg).
• The mean phosphorylase ratio in MH-susceptible patients (14.5 ± 2.0%) was not significantly different from non-susceptible patients (12.4 ± 1.9%).
• A significant overlap in phosphorylase ratios was observed between susceptible and non-susceptible groups, with numerous false positives.

Conclusions:

• The muscle phosphorylase ratio is not a reliable or definitive diagnostic test for screening malignant hyperthermia susceptibility.
• The high rate of false-positive results in non-susceptible individuals precludes its clinical use for MH screening.